Localization of indoleamine 2,3-dioxygenase in human esophageal squamous cell carcinomas

Virchows Archiv

Volumn 455, Issue 5, 2009, Pages 441-448

  Liu, Jinzhong ^a   Lu, Gaofeng ^a   Tang, Fuai ^a   Liu, Yiqing ^a   Cui, Guanglin ^a,b  

^a ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

Carcinoma; Esophagus; Immunosuppression

Indexed keywords

CD68 ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; PROTEIN S 100; SMOOTH MUSCLE ACTIN;

ADULT; AGED; ARTICLE; CELL DENSITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LOCALIZATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; MALE; MIDDLE AGED; NEOPLASM STAGING; STROMAL CELLS; TUMOR ESCAPE; TUMOR MARKERS, BIOLOGICAL;

EID: 73349117470     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0846-3     Document Type: Article

References (45)

1. DM Parkin FI Bray SS Devesa 2001 Cancer burden in the year 2000. The global picture Eur J Cancer 37 Suppl 8 S4 S66
2. MX Li SJ Cheng 1984 Carcinogenesis of esophageal cancer in Linxian, China Chin Med J (Engl) 97 311 316
3. JL Wee D Christiansen YQ Li, et al. 2008 Suppression of cytotoxic and proliferative xenogeneic T-cell responses by transgenic expression of indoleamine 2,3-dioxygenase Immunol Cell Biol 86 460 465
4. DH Hamilton PA Bretscher 2008 Different immune correlates associated with tumor progression and regression: implications for prevention and treatment of cancer Cancer Immunol Immunother 57 1125 1136
5. DO Croci MF Zacarias Fluck MJ Rico, et al. 2007 Dynamic cross-talk between tumor and immune cells in orchestrating the immunosuppressive network at the tumor microenvironment Cancer Immunol Immunother 56 1687 1700
6. M Westerterp MA Boermeester JM Omloo, et al. 2008 Differential responses of cellular immunity in patients undergoing neoadjuvant therapy followed by surgery for carcinoma of the oesophagus Cancer Immunol Immunother 57 1837 1847
7. M Gholamin O Moaven B Memar, et al. 2009 Overexpression and interactions of interleukin-10, transforming growth factor Beta, and vascular endothelial growth factor in esophageal squamous cell carcinoma World J Surg 33 1439 1445
8. H Shimada Y Nabeya S Okazumi, et al. 2003 Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma Dis Esophagus 16 102 106 (Pubitemid 36992382)
9. GC O'Sullivan AR Corbett F Shanahan, et al. 1996 Regional immunosuppression in esophageal squamous cancer: Evidence from functional studies with matched lymph nodes J Immunol 157 4717 4720
10. G Brandacher A Perathoner R Ladurner, et al. 2006 Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells Clin Cancer Res 12 1144 1151
11. A Curti S Trabanelli V Salvestrini, et al. 2009 The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology Blood 113 2394 2401
12. C Feder-Mengus S Wyler T Hudolin, et al. 2008 High expression of indoleamine 2,3-dioxygenase gene in prostate cancer Eur J Cancer 44 2266 2275
13. K Ino N Yoshida H Kajiyama, et al. 2006 Indoleamine 2,3-dioxygenase is a novel prognostic indicator for endometrial cancer Br J Cancer 95 1555 1561
14. V Karanikas M Zamanakou T Kerenidi, et al. 2007 Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer Cancer Biol Ther 6 1258 1262
15. K Pan H Wang MS Chen, et al. 2008 Expression and prognosis role of indoleamine 2,3-dioxygenase in hepatocellular carcinoma J Cancer Res Clin Oncol 134 1247 1253
16. GC Prendergast 2008 Immune escape as a fundamental trait of cancer: focus on IDO Oncogene 27 3889 3900
17. M Zamanakou AE Germenis V Karanikas 2007 Tumor immune escape mediated by indoleamine 2,3-dioxygenase Immunol Lett 111 69 75
18. S Lob A Konigsrainer D Zieker, et al. 2009 IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism Cancer Immunol Immunother 58 153 157
19. K Sakurai K Enomoto S Amano, et al. 2004 Study of indoleamine 2,3-dioxygenase expression in patients of esophageal squamous cell carcinoma Gan To Kagaku Ryoho 31 1780 1782 15553713
20. R Riesenberg C Weiler O Spring, et al. 2007 Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma Clin Cancer Res 13 6993 7002
21. P Sedlmayr M Semlitsch G Gebru, et al. 2003 Expression of indoleamine 2,3-dioxygenase in carcinoma of human endometrium and uterine cervix Adv Exp Med Biol 527 91 95
22. T Ishio S Goto K Tahara, et al. 2004 Immunoactivative role of indoleamine 2,3-dioxygenase in human hepatocellular carcinoma J Gastroenterol Hepatol 19 319 326
23. A Yuan J Liu Y Liu, et al. 2008 Immunohistochemical examination of gastrin, gastrin precursors, and gastrin/CCK-2 receptor in human esophageal squamous cell carcinomas Pathol Oncol Res 14 449 455
24. A Yuan J Liu Y Liu, et al. 2007 Chromogranin A-positive tumor cells in human esophageal squamous cell carcinomas Pathol Oncol Res 13 321 325 (Pubitemid 351287313)
25. G Cui A Yuan R Goll, et al. 2009 Dynamic changes of interleukin-8 network along the colorectal adenoma-carcinoma sequence Cancer Immunol Immunother 58 1897 1905
26. G Cui A Yuan B Vonen, et al. 2009 Progressive cellular response in the lamina propria of the colorectal adenoma-carcinoma sequence Histopathology 54 550 560
27. AJ Muller MD Sharma PR Chandler, et al. 2008 Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase Proc Natl Acad Sci USA 105 17073 17078
28. A Witkiewicz TK Williams J Cozzitorto, et al. 2008 Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection J Am Coll Surg 206 849 854
29. G Cui R Goll T Olsen, et al. 2007 Reduced expression of microenvironmental Th1 cytokines accompanies adenomas-carcinomas sequence of colorectum Cancer Immunol Immunother 56 985 995
30. C Uyttenhove L Pilotte I Theate, et al. 2003 Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase Nat Med 9 1269 1274
31. O Takikawa R Yoshida R Kido, et al. 1986 Tryptophan degradation in mice initiated by indoleamine 2,3-dioxygenase J Biol Chem 261 3648
32. DH Munn AL Mellor 2007 Indoleamine 2,3-dioxygenase and tumor-induced tolerance J Clin Invest 117 1147 1154
33. AJ Muller GC Prendergast 2007 Indoleamine 2,3-dioxygenase in immune suppression and cancer Curr Cancer Drug Targets 7 31 40
34. R Kim M Emi K Tanabe, et al. 2006 Tumor-driven evolution of immunosuppressive networks during malignant progression Cancer Res 66 5527 5536
35. SJ Guo DM Lin J Li, et al. 2007 Tumor-associated macrophages and CD3-zeta expression of tumor-infiltrating lymphocytes in human esophageal squamous-cell carcinoma Dis Esophagus 20 107 116
36. N Sadanaga H Kuwano M Watanabe, et al. 1994 Local immune response to tumor invasion in esophageal squamous cell carcinoma. The expression of human leukocyte antigen-DR and lymphocyte infiltration Cancer 74 586 591
37. C Zhang L Fu J Fu, et al. 2009 Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma Clin Cancer Res 15 4017 4027
38. S Tsuzuki H Ota M Hayama, et al. 2001 Proliferation of alpha-smooth muscle actin-containing stromal cells (myofibroblasts) in the lamina propria subjacent to intraepithelial carcinoma of the esophagus Scand J Gastroenterol 36 86 91
39. TL Whiteside 2006 The role of immune cells in the tumor microenvironment Cancer Treat Res 130 103 124
40. C Brigati DM Noonan A Albini, et al. 2002 Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19 247 258
41. CE Lewis JW Pollard 2006 Distinct role of macrophages in different tumor microenvironments Cancer Res 66 605 612
42. B Lieubeau MF Heymann F Henry, et al. 1999 Immunomodulatory effects of tumor-associated fibroblasts in colorectal-tumor development Int J Cancer 81 629 636
43. O Takikawa 2005 Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated l-tryptophan metabolism Biochem Biophys Res Commun 338 12 19
44. A Popov JL Schultze 2008 IDO-expressing regulatory dendritic cells in cancer and chronic infection J Mol Med 86 145 160
45. S Lob A Konigsrainer HG Rammensee, et al. 2009 Inhibitors of indoleamine-2,3-dioxygenase for cancer therapy: can we see the wood for the trees? Nat Rev Cancer 9 445 452